Company Filing History:
Years Active: 2023
Title: Junyun Lai - Innovator in Antigen Binding Molecules
Introduction
Junyun Lai is a notable inventor based in Singapore, recognized for his contributions to the field of biotechnology. He has developed innovative antigen binding molecules that have significant implications in medical research and treatment.
Latest Patents
Junyun Lai holds a patent for "IL2Rbeta/common gamma chain antibodies." This patent discloses antigen binding molecules capable of binding to CD122 and/or the common gamma chain (CD132). Additionally, it includes compositions comprising such antigen binding molecules, along with various uses and methods utilizing these innovations.
Career Highlights
Throughout his career, Junyun Lai has worked with prominent organizations, including the Agency for Science, Technology and Research and Euchloe Bio Pte. Ltd. His work in these institutions has contributed to advancements in biotechnology and therapeutic development.
Collaborations
Junyun has collaborated with esteemed colleagues such as Peter Brauer and John Edward Connolly, further enhancing the impact of his research and innovations.
Conclusion
Junyun Lai's work in developing antigen binding molecules showcases his commitment to advancing biotechnology. His contributions are paving the way for future innovations in medical treatments and research.